Pharmacogenomics: Recent advances and future directions - Cancer

Pharmacogenomics: Recent advances and future directions - Cancer

FOCUS

For hierarchy

Pharmacogenomics: Recent advances and future directions

The Journal of Human Genetics is pleased to present its first "special section" in the June issue of the journal. These special sections are designed to bring together collections of papers on specific topics of interest; guest editors curate the section, inviting contributions from leading researchers in the field. The topic of the first special section is pharmacogenomics, featuring eight articles on the current state of pharmacogenomics research and its implementation in the clinic.

Editorial |
Reviews |
Original Articles |

Top of page

Editorial

Special Section on Pharmacogenomics: recent advances and future directions FREE

Taisei Mushiroda, Kathleen M Giacomini and Michiaki Kubo

J Hum Genet 58: 305; doi:10.1038/jhg.2013.53

Abstract | Full Text | PDF

Top of page

Reviews

Pharmacogenomics of endocrine therapy in breast cancer Open

James N Ingle

J Hum Genet 58: 306-312; advance online publication, May 2, 2013; doi:10.1038/jhg.2013.35

Abstract | Full Text | PDF

Characteristics of pharmacogenomics/biomarker-guided clinical trials for regulatory approval of anti-cancer drugs in Japan

Akihiro Ishiguro, Satomi Yagi and Yoshiaki Uyama

J Hum Genet 58: 313-316; advance online publication, May 9, 2013; doi:10.1038/jhg.2013.36

Abstract | Full Text | PDF

Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury FREE

Nahoko Kaniwa and Yoshiro Saito

J Hum Genet 58: 317-326; advance online publication, May 2, 2013; doi:10.1038/jhg.2013.37

Abstract | Full Text | PDF

Important and critical scientific aspects in pharmacogenomics analysis: lessons from controversial results of tamoxifen and CYP2D6 studies FREE

Kazuma Kiyotani, Taisei Mushiroda, Hitoshi Zembutsu and Yusuke Nakamura

J Hum Genet 58: 327-333; advance online publication, May 9, 2013; doi:10.1038/jhg.2013.39

Abstract | Full Text | PDF

Pharmacogenetics of warfarin: challenges and opportunities

Ming Ta Michael Lee and Teri E Klein

J Hum Genet 58: 334-338; advance online publication, May 9, 2013; doi:10.1038/jhg.2013.40

Abstract | Full Text | PDF

Pharmacogenomics of anti-platelet therapy: how much evidence is enough for clinical implementation?

Christina G Perry and Alan R Shuldiner

J Hum Genet 58: 339-345; advance online publication, May 23, 2013; doi:10.1038/jhg.2013.41

Abstract | Full Text | PDF

Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity FREE

Daniel L Hertz and Howard L McLeod

J Hum Genet 58: 346-352; advance online publication, May 16, 2013; doi:10.1038/jhg.2013.42

Abstract | Full Text | PDF

Top of page

Original Article

Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia

Sook Wah Yee, Joel A Mefford, Natasha Singh, Mary-Elizabeth Percival, Adrian Stecula, Kuo Yang, John S Witte, Atsushi Takahashi, Michiaki Kubo, Koichi Matsuda, Kathleen M Giacomini and Charalambos Andreadisi

J Hum Genet 58: 353-361; advance online publication, May 16, 2013; doi:10.1038/jhg.2013.38

Abstract | Full Text | PDF